OmniAb (OABI) Amortizatization of Intangibles (2022 - 2026)
OmniAb's (OABI) quarterly Amortizatization of Intangibles came in at $199000.0 in Q1 2026, down 16.74% year-on-year from $239000.0 in Q1 2025, and down 18.44% on a QoQ basis from $244000.0 in Q4 2025.
OmniAb (OABI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Amortizatization of Intangibles data on file, last reported at $199000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 16.74% year-over-year to $199000.0 in Q1 2026; TTM through Mar 2026 was $818000.0, a 26.64% decrease from a year earlier, with the FY2025 full-year figure at $858000.0, down 42.72% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $199000.0, down from $244000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for OABI reached as high as $933000.0 in Q1 2023 and fell as low as $170000.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $440428.6 across 5 years, with a median of $265000.0 in 2024.
- Across the five-year window, Amortizatization of Intangibles surged 364.71% in 2023 and tumbled 73.04% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $170000.0 in 2022, then soared by 364.71% to $790000.0 in 2023, then tumbled by 73.04% to $213000.0 in 2024, then rose by 14.55% to $244000.0 in 2025, then declined by 18.44% to $199000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $199000.0 in Q1 2026, $244000.0 in Q4 2025, and $172000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | OmniAb | 260.98 Mn | 211.91 Mn | 14.41 Mn | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199,000.00 |
| Mar 31, 2026 | 199,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Dec 31, 2023 | 790,000.00 |